medigraphic.com
ENGLISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2013, Número 606

<< Anterior Siguiente >>

Rev Med Cos Cen 2013; 70 (606)


Gangrena de fournier

Trejos MS, Torrealba AM
Texto completo Cómo citar este artículo

Idioma: Español
Referencias bibliográficas: 28
Paginas: 351-357
Archivo PDF: 211.79 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

La Gangrena de Fournier es una forma de fasceitis necrotizante que produce destrucción fulminante del tejido, síntomas sistémicos de toxicidad y una alta tasa de mortalidad. Debe sospecharse en pacientes con fiebre, toxicidad, compromiso de tejidos blandos, con dolor no proporcional a los hallazgos en piel. El diagnóstico certero y el tratamiento apropiado debe incluir intervención quirúrgica temprana y debridamientos quirúrgicos repetidos para definir la extensión de la enfermedad y resecar el tejido necrótico, antibióticos y soporte hemodinámico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Aebi, C, Ahmed, A, Ramilo,O. Bacterial complications of primary varicella in children. Clin Infect Dis 1996; 23:698.

  2. Anaya, DA, Patchen Dellinger, E. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44:705.

  3. Bejarga BE: Fournier‘s gangrene. Br J Urol 1979;51:312

  4. Butterworth, SA, Murphy, JJ. Necrotizing soft tissue infections--are they different in healthy vs immunocompromised children?. J Pediatr Surg 2006; 41:935.

  5. Campbell –Walsh Urology 9º Edition, 2007.

  6. Carmin M. Kalorin, Ellis H. Tobin: Community Associated Methicillin Resistant Staphylococcus Aureus Causing Fournier‘s Gangrene and Genital Infections. J Urol. Vol. 177, Issue 3, Pag. 967-971, March 2007.

  7. Chelsom, J, Halstensen, A, Haga, T, Hoiby, EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344:1111.

  8. Erich K. Lang, Amer Hanano, Ernest Rudman: Computarized Tomography of Gangrene. J Urol. Vol. 183, Issue 2, Pag. 740, February 2010.

  9. Fournier JA: Etude clinique de la gangrene-foudroyante de la verge. Semin Med 1884;4:69.

  10. Fournier JA: Gangrene-foudroyante de la verge. Semin Med 1883;3:345.

  11. Jamil Rehman, Ayal Kaynan, David Samadi: Air on Radiography of Perineal Necrotizing Fasciitis Indicates Testis Involvement. J Urol. Vol. 162, Issue 6, Pag. 2101, December 1999.

  12. Laucks, SS 2nd. Fournier’s gangrene. Surg Clin North Am 1994; 74:1339.

  13. M. Capelli-Schelpfeffer, Glenn S. Gerber: The Use of Hyperbaric Oxigen in Urology. J Urol. Vol. 162, Issue 3, Pag. 647-654, September 1999.

  14. Mathew D. Sorense, John N Krieger, Frederick P. Rivana: Fournier‘s Gangrene: Population Based Epidemiology and Outcomes. J Urol. Vol. 181, Issue 5, Pag. 2120-2126, May 2009.

  15. Miller, LG, Perdreau-Remington, F, Rieg, G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445.

  16. R Pizzorno, F Bonini, A Donelli: Hyperbaric Oxigen Therapy in the Treatment of Fournire‘s Disease in 11 Male Patients. J Urol. Vol. 158, Issue 3, Pag. 837-840, September 1997.

  17. Schmid, MR, Kossmann, T, Duewell, S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 1998; 170:615.

  18. Simonart, T, Simonart, JM, Derdelinckx, I, et al. Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 2001; 32:E9.

  19. Stephens, BJ, Lathrop, JC, Rice, WT, Gruenberg, JC. Fournier’s gangrene: Historic (1764-1978) versus contemporary (1979-1988) differences in etiology and clinical importance. Am Surg 1993; 59:149.

  20. Steven R. Mindrup, G. Patrick Kealey, Bernard Fallon: Hyperbaric Oxigen for the Treatment of Fournire‘s Gangrene. J Urol. Vol. 173, Issue 6, Pag. 1975-1977, June 2005.

  21. Stevens, DL, Tanner, MH, Winship, J, et al. Severe group A streptococcal infections associated with a toxic shocklike syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1.

  22. Stevens, DL. Streptococcal toxic shock syndrome: Spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1995; 1:69.

  23. Sudarsky, LA, Laschinger, JC, Coppa, GF, Spencer, FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 1987; 206:661.

  24. Wolach MD, MacDermott JP, DeVere White RW: Treatment and complications of Fournier‘s gangrene. Br J Urol 1989;64:310

  25. Wong, CH, Chang, HC, Pasupathy, S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85-A:1454.

  26. Wong, CH, Khin, LW, Heng, KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32:1535

  27. Yeniyol, CO, Suelozgen, T, Arslan, M, Ayder, AR. Fournier’s gangrene: experience with 25 patients and use of Fournier’s gangrene severity index score. Urology 2004; 64:218.

  28. Zacharias, N, Velmahos, GC, Salama, A, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg 2010; 145:452.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2013;70

ARTíCULOS SIMILARES

CARGANDO ...